Adicet Bio, Inc. (ACET) earnings
ACET earnings moved a median of -1.91% by the close. Quarterly and annual ACET reports and results, each read against the price at its own news timestamp. Back to the ACET overview →
22 measured ACET earnings events.
Where these ACET earnings landedvs 22 measured ACET earnings reactions
| Middle 50% of ACET earnings reactions | -7.47% to +1.92% |
|---|---|
| Median reaction (to close) | -1.91% |
| Measured reactions | 22 |
Point-in-time · zero look-ahead
Half of the 22 ACET earnings events with a measured close landed between -7.47% and +1.92%; 36% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Adicet Bio Reports Second Quarter 2026 Financial Results and Provides Business Updates | Press release | -8.61% | -8.96% | |
| Form 10-Q Adicet Bio, Inc. For: Jun 30 | SEC filing · Form 10-Q | -8.61% | -8.96% | |
| Form 10-K/A Adicet Bio, Inc. For: Dec 31 | SEC filing · Form 10-K | -0.78% | +2.33% | |
| Adicet Bio Reports First Quarter 2026 Financial Results and Provides Business Updates | Press release | +0.61% | +3.19% | |
| Form 10-Q Adicet Bio, Inc. For: Mar 31 | SEC filing · Form 10-Q | +0.61% | +3.19% | |
| Form 10-K Adicet Bio, Inc. For: Dec 31 | SEC filing · Form 10-K | +9.17% | +3.29% | |
| Adicet Bio Reports Third Quarter 2025 Financial Results and Provides Business Updates | Press release | +0.01% | -1.91% | |
| Form 10-Q Adicet Bio, Inc. For: Sep 30 | SEC filing · Form 10-Q | +0.01% | -1.91% | |
| Adicet Bio Reports Second Quarter 2025 Financial Results and Provides Business Updates | Press release | +1.42% | -8.68% | |
| Form 10-Q Adicet Bio, Inc. For: Jun 30 | SEC filing · Form 10-Q | +1.42% | -8.68% | |
| Adicet Bio Reports First Quarter 2025 Financial Results and Provides Business Updates | Press release | +0.57% | -18.27% | |
| Form 10-Q Adicet Bio, Inc. For: Mar 31 | SEC filing · Form 10-Q | +0.57% | -18.27% | |
| Form 10-K Adicet Bio, Inc. For: Dec 31 | SEC filing · Form 10-K | +2.94% | -2.92% | |
| Adicet Reports Third Quarter 2024 Financial Results and Provides Business Updates | Press release | +3.08% | +2.31% | |
| Form 10-Q Adicet Bio, Inc. For: Sep 30 | SEC filing · Form 10-Q | +3.08% | +2.31% | |
| Adicet Reports Second Quarter 2024 Financial Results and Provides Business Updates | Press release | -0.39% | +0.78% | |
| Form 10-Q Adicet Bio, Inc. For: Jun 30 | SEC filing · Form 10-Q | -0.39% | +0.78% | |
| Adicet Reports First Quarter 2024 Financial Results and Provides Business Updates | Press release | +6.03% | -0.71% | |
| Form 10-Q Adicet Bio, Inc. For: Mar 31 | SEC filing · Form 10-Q | +6.03% | -0.71% | |
| Form 10-K Adicet Bio, Inc. For: Dec 31 | SEC filing · Form 10-K | -2.25% | -3.60% | |
| Adicet Reports Third Quarter 2023 Financial Results and Provides Business Updates | Press release | -2.69% | -3.85% | |
| Form 10-Q Adicet Bio, Inc. For: Sep 30 | SEC filing · Form 10-Q | -2.69% | -3.85% |
Keep exploring
More ACET: analyst actions → · SEC filings → · ACET overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| CRISPR Therapeutics AG - Common Shares (CRSP) | 291 | +0.10% | 53% |
| Seres Therapeutics, Inc. (MCRB) | 290 | -0.23% | 46% |
| Xencor, Inc. (XNCR) | 288 | +0.09% | 51% |
| Accuray Incorporated (ARAY) | 286 | 0.00% | 50% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.